Table of Content

1 Market Overview of Targeted Radionuclide Drug
1.1 Targeted Radionuclide Drug Market Overview
1.1.1 Targeted Radionuclide Drug Product Scope
1.1.2 Targeted Radionuclide Drug Market Status and Outlook
1.2 Global Targeted Radionuclide Drug Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Targeted Radionuclide Drug Market Size by Region (2018-2033)
1.4 Global Targeted Radionuclide Drug Historic Market Size by Region (2018-2023)
1.5 Global Targeted Radionuclide Drug Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Targeted Radionuclide Drug Market Size (2018-2033)
1.6.1 North America Targeted Radionuclide Drug Market Size (2018-2033)
1.6.2 Europe Targeted Radionuclide Drug Market Size (2018-2033)
1.6.3 Asia-Pacific Targeted Radionuclide Drug Market Size (2018-2033)
1.6.4 Latin America Targeted Radionuclide Drug Market Size (2018-2033)
1.6.5 Middle East & Africa Targeted Radionuclide Drug Market Size (2018-2033)
2 Targeted Radionuclide Drug Market by Type
2.1 Introduction
2.1.1 Medicine
2.1.2 Inhibitor
2.2 Global Targeted Radionuclide Drug Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Targeted Radionuclide Drug Historic Market Size by Type (2018-2023)
2.2.2 Global Targeted Radionuclide Drug Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Targeted Radionuclide Drug Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Targeted Radionuclide Drug Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Targeted Radionuclide Drug Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Targeted Radionuclide Drug Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Targeted Radionuclide Drug Revenue Breakdown by Type (2018-2033)
3 Targeted Radionuclide Drug Market Overview by Application
3.1 Introduction
3.1.1 Tumors
3.1.2 Thyroid
3.1.3 Others
3.2 Global Targeted Radionuclide Drug Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Targeted Radionuclide Drug Historic Market Size by Application (2018-2023)
3.2.2 Global Targeted Radionuclide Drug Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Targeted Radionuclide Drug Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Targeted Radionuclide Drug Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Targeted Radionuclide Drug Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Targeted Radionuclide Drug Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Targeted Radionuclide Drug Revenue Breakdown by Application (2018-2033)
4 Targeted Radionuclide Drug Competition Analysis by Players
4.1 Global Targeted Radionuclide Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Radionuclide Drug as of 2022)
4.3 Date of Key Players Enter into Targeted Radionuclide Drug Market
4.4 Global Top Players Targeted Radionuclide Drug Headquarters and Area Served
4.5 Key Players Targeted Radionuclide Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Targeted Radionuclide Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 POINT Biopharma
5.1.1 POINT Biopharma Profile
5.1.2 POINT Biopharma Main Business
5.1.3 POINT Biopharma Targeted Radionuclide Drug Products, Services and Solutions
5.1.4 POINT Biopharma Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.1.5 POINT Biopharma Recent Developments
5.2 Telix
5.2.1 Telix Profile
5.2.2 Telix Main Business
5.2.3 Telix Targeted Radionuclide Drug Products, Services and Solutions
5.2.4 Telix Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.2.5 Telix Recent Developments
5.3 ITM AG
5.3.1 ITM AG Profile
5.3.2 ITM AG Main Business
5.3.3 ITM AG Targeted Radionuclide Drug Products, Services and Solutions
5.3.4 ITM AG Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer AG Recent Developments
5.4 Bayer AG
5.4.1 Bayer AG Profile
5.4.2 Bayer AG Main Business
5.4.3 Bayer AG Targeted Radionuclide Drug Products, Services and Solutions
5.4.4 Bayer AG Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer AG Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Targeted Radionuclide Drug Products, Services and Solutions
5.5.4 Novartis Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Lantheus
5.6.1 Lantheus Profile
5.6.2 Lantheus Main Business
5.6.3 Lantheus Targeted Radionuclide Drug Products, Services and Solutions
5.6.4 Lantheus Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.6.5 Lantheus Recent Developments
5.7 Curium Pharma
5.7.1 Curium Pharma Profile
5.7.2 Curium Pharma Main Business
5.7.3 Curium Pharma Targeted Radionuclide Drug Products, Services and Solutions
5.7.4 Curium Pharma Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.7.5 Curium Pharma Recent Developments
5.8 Fusion Pharmaceuticals
5.8.1 Fusion Pharmaceuticals Profile
5.8.2 Fusion Pharmaceuticals Main Business
5.8.3 Fusion Pharmaceuticals Targeted Radionuclide Drug Products, Services and Solutions
5.8.4 Fusion Pharmaceuticals Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.8.5 Fusion Pharmaceuticals Recent Developments
5.9 RadioMedix, Inc.
5.9.1 RadioMedix, Inc. Profile
5.9.2 RadioMedix, Inc. Main Business
5.9.3 RadioMedix, Inc. Targeted Radionuclide Drug Products, Services and Solutions
5.9.4 RadioMedix, Inc. Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.9.5 RadioMedix, Inc. Recent Developments
5.10 Convergent Therapeutics
5.10.1 Convergent Therapeutics Profile
5.10.2 Convergent Therapeutics Main Business
5.10.3 Convergent Therapeutics Targeted Radionuclide Drug Products, Services and Solutions
5.10.4 Convergent Therapeutics Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.10.5 Convergent Therapeutics Recent Developments
5.11 IONETIX
5.11.1 IONETIX Profile
5.11.2 IONETIX Main Business
5.11.3 IONETIX Targeted Radionuclide Drug Products, Services and Solutions
5.11.4 IONETIX Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.11.5 IONETIX Recent Developments
5.12 Clarity Pharmaceuticals
5.12.1 Clarity Pharmaceuticals Profile
5.12.2 Clarity Pharmaceuticals Main Business
5.12.3 Clarity Pharmaceuticals Targeted Radionuclide Drug Products, Services and Solutions
5.12.4 Clarity Pharmaceuticals Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.12.5 Clarity Pharmaceuticals Recent Developments
5.13 RayzeBio, Inc
5.13.1 RayzeBio, Inc Profile
5.13.2 RayzeBio, Inc Main Business
5.13.3 RayzeBio, Inc Targeted Radionuclide Drug Products, Services and Solutions
5.13.4 RayzeBio, Inc Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.13.5 RayzeBio, Inc Recent Developments
5.14 AmbioPharm
5.14.1 AmbioPharm Profile
5.14.2 AmbioPharm Main Business
5.14.3 AmbioPharm Targeted Radionuclide Drug Products, Services and Solutions
5.14.4 AmbioPharm Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.14.5 AmbioPharm Recent Developments
5.15 Bracco Imaging
5.15.1 Bracco Imaging Profile
5.15.2 Bracco Imaging Main Business
5.15.3 Bracco Imaging Targeted Radionuclide Drug Products, Services and Solutions
5.15.4 Bracco Imaging Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.15.5 Bracco Imaging Recent Developments
5.16 Navidea
5.16.1 Navidea Profile
5.16.2 Navidea Main Business
5.16.3 Navidea Targeted Radionuclide Drug Products, Services and Solutions
5.16.4 Navidea Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.16.5 Navidea Recent Developments
5.17 China Isotope & Radiation Corporation
5.17.1 China Isotope & Radiation Corporation Profile
5.17.2 China Isotope & Radiation Corporation Main Business
5.17.3 China Isotope & Radiation Corporation Targeted Radionuclide Drug Products, Services and Solutions
5.17.4 China Isotope & Radiation Corporation Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.17.5 China Isotope & Radiation Corporation Recent Developments
5.18 Yantai Dongcheng
5.18.1 Yantai Dongcheng Profile
5.18.2 Yantai Dongcheng Main Business
5.18.3 Yantai Dongcheng Targeted Radionuclide Drug Products, Services and Solutions
5.18.4 Yantai Dongcheng Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.18.5 Yantai Dongcheng Recent Developments
5.19 Grand Pharma
5.19.1 Grand Pharma Profile
5.19.2 Grand Pharma Main Business
5.19.3 Grand Pharma Targeted Radionuclide Drug Products, Services and Solutions
5.19.4 Grand Pharma Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.19.5 Grand Pharma Recent Developments
5.20 Hengrui Medicine
5.20.1 Hengrui Medicine Profile
5.20.2 Hengrui Medicine Main Business
5.20.3 Hengrui Medicine Targeted Radionuclide Drug Products, Services and Solutions
5.20.4 Hengrui Medicine Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.20.5 Hengrui Medicine Recent Developments
5.21 Yunnan Baiyao Group
5.21.1 Yunnan Baiyao Group Profile
5.21.2 Yunnan Baiyao Group Main Business
5.21.3 Yunnan Baiyao Group Targeted Radionuclide Drug Products, Services and Solutions
5.21.4 Yunnan Baiyao Group Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.21.5 Yunnan Baiyao Group Recent Developments
5.22 SmartNuclide Biopharma
5.22.1 SmartNuclide Biopharma Profile
5.22.2 SmartNuclide Biopharma Main Business
5.22.3 SmartNuclide Biopharma Targeted Radionuclide Drug Products, Services and Solutions
5.22.4 SmartNuclide Biopharma Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.22.5 SmartNuclide Biopharma Recent Developments
5.23 Sinotau
5.23.1 Sinotau Profile
5.23.2 Sinotau Main Business
5.23.3 Sinotau Targeted Radionuclide Drug Products, Services and Solutions
5.23.4 Sinotau Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.23.5 Sinotau Recent Developments
5.24 Hexin Pharmaceutical
5.24.1 Hexin Pharmaceutical Profile
5.24.2 Hexin Pharmaceutical Main Business
5.24.3 Hexin Pharmaceutical Targeted Radionuclide Drug Products, Services and Solutions
5.24.4 Hexin Pharmaceutical Targeted Radionuclide Drug Revenue (US$ Million) & (2018-2023)
5.24.5 Hexin Pharmaceutical Recent Developments
6 North America
6.1 North America Targeted Radionuclide Drug Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Targeted Radionuclide Drug Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Targeted Radionuclide Drug Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Targeted Radionuclide Drug Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Targeted Radionuclide Drug Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Targeted Radionuclide Drug Market Dynamics
11.1 Targeted Radionuclide Drug Industry Trends
11.2 Targeted Radionuclide Drug Market Drivers
11.3 Targeted Radionuclide Drug Market Challenges
11.4 Targeted Radionuclide Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Targeted Radionuclide Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Targeted Radionuclide Drug Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Targeted Radionuclide Drug Market Size Share by Region (2018-2023)
Table 4. Global Targeted Radionuclide Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Targeted Radionuclide Drug Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Targeted Radionuclide Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Targeted Radionuclide Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Targeted Radionuclide Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Targeted Radionuclide Drug Revenue Market Share by Type (2024-2033)
Table 11. North America Targeted Radionuclide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Targeted Radionuclide Drug Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Targeted Radionuclide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Targeted Radionuclide Drug Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Targeted Radionuclide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Targeted Radionuclide Drug Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Targeted Radionuclide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Targeted Radionuclide Drug Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Targeted Radionuclide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Targeted Radionuclide Drug Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Targeted Radionuclide Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Targeted Radionuclide Drug Revenue Market Share by Application (2018-2023)
Table 24. Global Targeted Radionuclide Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Targeted Radionuclide Drug Revenue Market Share by Application (2024-2033)
Table 26. North America Targeted Radionuclide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Targeted Radionuclide Drug Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Targeted Radionuclide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Targeted Radionuclide Drug Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Targeted Radionuclide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Targeted Radionuclide Drug Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Targeted Radionuclide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Targeted Radionuclide Drug Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Targeted Radionuclide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Targeted Radionuclide Drug Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Targeted Radionuclide Drug Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Targeted Radionuclide Drug Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Radionuclide Drug as of 2022)
Table 39. Date of Key Players Enter into Targeted Radionuclide Drug Market
Table 40. Global Targeted Radionuclide Drug Key Players Headquarters and Area Served
Table 41. Targeted Radionuclide Drug Product Solution and Service
Table 42. Global Targeted Radionuclide Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. POINT Biopharma Basic Information List
Table 45. POINT Biopharma Description and Business Overview
Table 46. POINT Biopharma Targeted Radionuclide Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Targeted Radionuclide Drug Business of POINT Biopharma (2018-2023)
Table 48. POINT Biopharma Recent Developments
Table 49. Telix Basic Information List
Table 50. Telix Description and Business Overview
Table 51. Telix Targeted Radionuclide Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Telix (2018-2023)
Table 53. Telix Recent Developments
Table 54. ITM AG Basic Information List
Table 55. ITM AG Description and Business Overview
Table 56. ITM AG Targeted Radionuclide Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Targeted Radionuclide Drug Business of ITM AG (2018-2023)
Table 58. ITM AG Recent Developments
Table 59. Bayer AG Basic Information List
Table 60. Bayer AG Description and Business Overview
Table 61. Bayer AG Targeted Radionuclide Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Bayer AG (2018-2023)
Table 63. Bayer AG Recent Developments
Table 64. Novartis Basic Information List
Table 65. Novartis Description and Business Overview
Table 66. Novartis Targeted Radionuclide Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Novartis (2018-2023)
Table 68. Novartis Recent Developments
Table 69. Lantheus Basic Information List
Table 70. Lantheus Description and Business Overview
Table 71. Lantheus Targeted Radionuclide Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Lantheus (2018-2023)
Table 73. Lantheus Recent Developments
Table 74. Curium Pharma Basic Information List
Table 75. Curium Pharma Description and Business Overview
Table 76. Curium Pharma Targeted Radionuclide Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Curium Pharma (2018-2023)
Table 78. Curium Pharma Recent Developments
Table 79. Fusion Pharmaceuticals Basic Information List
Table 80. Fusion Pharmaceuticals Description and Business Overview
Table 81. Fusion Pharmaceuticals Targeted Radionuclide Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Fusion Pharmaceuticals (2018-2023)
Table 83. Fusion Pharmaceuticals Recent Developments
Table 84. RadioMedix, Inc. Basic Information List
Table 85. RadioMedix, Inc. Description and Business Overview
Table 86. RadioMedix, Inc. Targeted Radionuclide Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Targeted Radionuclide Drug Business of RadioMedix, Inc. (2018-2023)
Table 88. RadioMedix, Inc. Recent Developments
Table 89. Convergent Therapeutics Basic Information List
Table 90. Convergent Therapeutics Description and Business Overview
Table 91. Convergent Therapeutics Targeted Radionuclide Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Convergent Therapeutics (2018-2023)
Table 93. Convergent Therapeutics Recent Developments
Table 94. IONETIX Basic Information List
Table 95. IONETIX Description and Business Overview
Table 96. IONETIX Targeted Radionuclide Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Targeted Radionuclide Drug Business of IONETIX (2018-2023)
Table 98. IONETIX Recent Developments
Table 99. Clarity Pharmaceuticals Basic Information List
Table 100. Clarity Pharmaceuticals Description and Business Overview
Table 101. Clarity Pharmaceuticals Targeted Radionuclide Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Clarity Pharmaceuticals (2018-2023)
Table 103. Clarity Pharmaceuticals Recent Developments
Table 104. RayzeBio, Inc Basic Information List
Table 105. RayzeBio, Inc Description and Business Overview
Table 106. RayzeBio, Inc Targeted Radionuclide Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Targeted Radionuclide Drug Business of RayzeBio, Inc (2018-2023)
Table 108. RayzeBio, Inc Recent Developments
Table 109. AmbioPharm Basic Information List
Table 110. AmbioPharm Description and Business Overview
Table 111. AmbioPharm Targeted Radionuclide Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in Targeted Radionuclide Drug Business of AmbioPharm (2018-2023)
Table 113. AmbioPharm Recent Developments
Table 114. Bracco Imaging Basic Information List
Table 115. Bracco Imaging Description and Business Overview
Table 116. Bracco Imaging Targeted Radionuclide Drug Products, Services and Solutions
Table 117. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Bracco Imaging (2018-2023)
Table 118. Bracco Imaging Recent Developments
Table 119. Navidea Basic Information List
Table 120. Navidea Description and Business Overview
Table 121. Navidea Targeted Radionuclide Drug Products, Services and Solutions
Table 122. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Navidea (2018-2023)
Table 123. Navidea Recent Developments
Table 124. China Isotope & Radiation Corporation Basic Information List
Table 125. China Isotope & Radiation Corporation Description and Business Overview
Table 126. China Isotope & Radiation Corporation Targeted Radionuclide Drug Products, Services and Solutions
Table 127. Revenue (US$ Million) in Targeted Radionuclide Drug Business of China Isotope & Radiation Corporation (2018-2023)
Table 128. China Isotope & Radiation Corporation Recent Developments
Table 129. Yantai Dongcheng Basic Information List
Table 130. Yantai Dongcheng Description and Business Overview
Table 131. Yantai Dongcheng Targeted Radionuclide Drug Products, Services and Solutions
Table 132. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Yantai Dongcheng (2018-2023)
Table 133. Yantai Dongcheng Recent Developments
Table 134. Grand Pharma Basic Information List
Table 135. Grand Pharma Description and Business Overview
Table 136. Grand Pharma Targeted Radionuclide Drug Products, Services and Solutions
Table 137. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Grand Pharma (2018-2023)
Table 138. Grand Pharma Recent Developments
Table 139. Hengrui Medicine Basic Information List
Table 140. Hengrui Medicine Description and Business Overview
Table 141. Hengrui Medicine Targeted Radionuclide Drug Products, Services and Solutions
Table 142. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Hengrui Medicine (2018-2023)
Table 143. Hengrui Medicine Recent Developments
Table 144. Yunnan Baiyao Group Basic Information List
Table 145. Yunnan Baiyao Group Description and Business Overview
Table 146. Yunnan Baiyao Group Targeted Radionuclide Drug Products, Services and Solutions
Table 147. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Yunnan Baiyao Group (2018-2023)
Table 148. Yunnan Baiyao Group Recent Developments
Table 149. SmartNuclide Biopharma Basic Information List
Table 150. SmartNuclide Biopharma Description and Business Overview
Table 151. SmartNuclide Biopharma Targeted Radionuclide Drug Products, Services and Solutions
Table 152. Revenue (US$ Million) in Targeted Radionuclide Drug Business of SmartNuclide Biopharma (2018-2023)
Table 153. SmartNuclide Biopharma Recent Developments
Table 154. Sinotau Basic Information List
Table 155. Sinotau Description and Business Overview
Table 156. Sinotau Targeted Radionuclide Drug Products, Services and Solutions
Table 157. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Sinotau (2018-2023)
Table 158. Sinotau Recent Developments
Table 159. Hexin Pharmaceutical Basic Information List
Table 160. Hexin Pharmaceutical Description and Business Overview
Table 161. Hexin Pharmaceutical Targeted Radionuclide Drug Products, Services and Solutions
Table 162. Revenue (US$ Million) in Targeted Radionuclide Drug Business of Hexin Pharmaceutical (2018-2023)
Table 163. Hexin Pharmaceutical Recent Developments
Table 164. North America Targeted Radionuclide Drug Market Size by Country (2018-2023) & (US$ Million)
Table 165. North America Targeted Radionuclide Drug Market Size by Country (2024-2033) & (US$ Million)
Table 166. Europe Targeted Radionuclide Drug Market Size by Country (2018-2023) & (US$ Million)
Table 167. Europe Targeted Radionuclide Drug Market Size by Country (2024-2033) & (US$ Million)
Table 168. Asia-Pacific Targeted Radionuclide Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 169. Asia-Pacific Targeted Radionuclide Drug Market Size by Region (2018-2023) & (US$ Million)
Table 170. Asia-Pacific Targeted Radionuclide Drug Market Size by Region (2024-2033) & (US$ Million)
Table 171. Asia-Pacific Targeted Radionuclide Drug Market Share by Region (2018-2023)
Table 172. Asia-Pacific Targeted Radionuclide Drug Market Share by Region (2024-2033)
Table 173. Latin America Targeted Radionuclide Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 174. Latin America Targeted Radionuclide Drug Market Size by Country (2018-2023) & (US$ Million)
Table 175. Latin America Targeted Radionuclide Drug Market Size by Country (2024-2033) & (US$ Million)
Table 176. Middle East & Africa Targeted Radionuclide Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 177. Middle East & Africa Targeted Radionuclide Drug Market Size by Country (2018-2023) & (US$ Million)
Table 178. Middle East & Africa Targeted Radionuclide Drug Market Size by Country (2024-2033) & (US$ Million)
Table 179. Targeted Radionuclide Drug Market Trends
Table 180. Targeted Radionuclide Drug Market Drivers
Table 181. Targeted Radionuclide Drug Market Challenges
Table 182. Targeted Radionuclide Drug Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Radionuclide Drug Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Targeted Radionuclide Drug Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Targeted Radionuclide Drug Market Share by Regions: 2022 VS 2033
Figure 4. Global Targeted Radionuclide Drug Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Targeted Radionuclide Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Medicine
Figure 11. Global Medicine Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Inhibitor
Figure 13. Global Inhibitor Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Targeted Radionuclide Drug Market Size Share by Type: 2022 & 2033
Figure 15. North America Targeted Radionuclide Drug Revenue Market Share by Type (2018-2033)
Figure 16. Europe Targeted Radionuclide Drug Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Targeted Radionuclide Drug Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Targeted Radionuclide Drug Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Targeted Radionuclide Drug Revenue Market Share by Type (2018-2033)
Figure 20. Tumors Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Thyroid Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global Targeted Radionuclide Drug Market Size Share by Application: 2022 & 2033
Figure 24. North America Targeted Radionuclide Drug Revenue Market Share by Application (2018-2033)
Figure 25. Europe Targeted Radionuclide Drug Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific Targeted Radionuclide Drug Revenue Market Share by Application (2018-2033)
Figure 27. Latin America Targeted Radionuclide Drug Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa Targeted Radionuclide Drug Revenue Market Share by Application (2018-2033)
Figure 29. Targeted Radionuclide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Targeted Radionuclide Drug Market Share in 2022
Figure 31. North America Targeted Radionuclide Drug Market Share by Country (2018-2033)
Figure 32. United States Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 33. Canada Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 34. Germany Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 35. France Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 37. Italy Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 38. Russia Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Targeted Radionuclide Drug Market Share by Region (2018-2033)
Figure 41. China Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 42. Japan Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 45. India Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 46. Australia Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America Targeted Radionuclide Drug Market Share by Country (2018-2033)
Figure 48. Mexico Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Targeted Radionuclide Drug Market Share by Country (2018-2033)
Figure 51. Turkey Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 53. UAE Targeted Radionuclide Drug Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report